Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-27

FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Children's Allegra Allergy containing fexofenadine hydrochloride, submitted by Chattem, Inc., to modify/expand its l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHILDRENS ALLEGRA ALLERGY (FEXOFENADINE HYDROCHLORIDE)

Snippet

SUPPL AP for CHILDRENS ALLEGRA ALLERGY (FEXOFENADINE HYDROCHLORIDE)